Jul 24, 2024
Luke Piggott, principal scientist at Debiopharm, has a unique business model in the drug discovery and development to commercialization landscape. Focusing on rare cancers, they license drugs from smaller biotechs and conduct clinical trials before out-licensing them to larger pharmaceutical companies with...
Jul 24, 2024
Luke Piggott, principal scientist at Debiopharm, has a unique business model in the drug discovery and development to commercialization landscape. Focusing on rare cancers, they license drugs from smaller biotechs and conduct clinical trials before out-licensing them to larger pharmaceutical companies with...
Mar 13, 2024
Cody Shandraw, President and Co-Founder of Healing Realty Trust, aims to provide robust mental and behavioral health treatment facilities. The lack of infrastructure has been a significant hurdle for expanding the commercialization of drugs that require longer in-office visits and space to accommodate the needs of...
Mar 13, 2024
Cody Shandraw, President and Co-Founder of Healing Realty Trust, aims to provide robust mental and behavioral health treatment facilities. The lack of infrastructure has been a significant hurdle for expanding the commercialization of drugs that require longer in-office visits and space to accommodate the needs of...
Nov 15, 2023
Cheryl Cheng, Founder and CEO of Vive Collective, discusses the unique business model of their investment platform, which focuses on digital health and health tech addressing large problems in healthcare, such as chronic conditions and complex workflows. Cheryl emphasizes the need for seamless integration of digital...